Tumor supernatant derived from hepatocellular carcinoma cells treated with vincristine sulfate have therapeutic activity
- 1 December 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 155, 105557
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hebei Province (H2015206101)
- National Natural Science Foundation of China (81470595)
This publication has 39 references indexed in Scilit:
- Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinomaCancer Letters, 2013
- RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG2 human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cellCancer Cell International, 2013
- Tao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor PathwayDevelopmental Cell, 2011
- Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cellsHepatology, 2011
- HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cellsDevelopment, 2011
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCPGenes & Development, 2010
- Yes‐associated protein is an independent prognostic marker in hepatocellular carcinomaCancer, 2009
- Protocol for the fast chromatin immunoprecipitation (ChIP) methodNature Protocols, 2006
- TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENTAnnual Review of Pathology: Mechanisms of Disease, 2006
- Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging ReagentsMolecular & Cellular Proteomics, 2004